Abstract

In the recent years, the progress in genetic analysis and next-generation sequencing technologies have opened up exciting landscapes for diagnosis and study of molecular mechanisms, allowing the determination of a particular mutation for individual patients suffering from hereditary red blood cell-related diseases or anemia. However, the huge amount of data obtained makes the interpretation of the results and the identification of the pathogenetic variant responsible for the diseases sometime difficult. Moreover, there is increasing evidence that the same mutation can result in varying cellular properties and different symptoms of the disease. Even for the same patient, the phenotypic expression of the disorder can change over time. Therefore, on top of genetic analysis, there is a further request for functional tests that allow to confirm the pathogenicity of a molecular variant, possibly to predict prognosis and complications (e.g., vaso-occlusive pain crises or other thrombotic events) and, in the best case, to enable personalized theranostics (drug and/or dose) according to the disease state and progression. The mini-review will reflect recent and future directions in the development of diagnostic tools for red blood cell-related diseases and anemias. This includes point of care devices, new incarnations of well-known principles addressing physico-chemical properties, and interactions of red blood cells as well as high-tech screening equipment and mobile laboratories.

MeSH

Erythrocytes, Anemia, Blood Cells, Mutation, Artificial Intelligence, Point-Of-Care Systems, High-Throughput Nucleotide Sequencing

Cited by

• Donor Age and Red Cell Age Contribute to the Variance in Lorrca Indices in Healthy Donors for Next Generation Ektacytometry: A Pilot Study. Front Physiol, 2021
• Red blood cell phenotyping from 3D confocal images using artificial neural networks. PLoS Comput Biol, 2021
• Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control. Transfus Med Hemother, 2023
• Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review. Front Med (Lausanne), 2023
• Early Career Scientists' Guide to the Red Blood Cell - Don't Panic! Front Physiol, 2020
• Gene Editing for Inherited Red Blood Cell Diseases. Front Physiol, 2022
• Lysophosphatidic Acid-Activated Calcium Signaling Is Elevated in Red Cells from Sickle Cell Disease Patients. Cells, 2021
• Emerging point-of-care technologies for anemia detection. Lab Chip, 2021
• Rare Anemias: Are Their Names Just Smoke and Mirrors? Front Physiol, 2021
• Erysense, a Lab-on-a-Chip-Based Point-of-Care Device to Evaluate Red Blood Cell Flow Properties With Multiple Clinical Applications. Front Physiol, 2022